SpringWorks Therapeutics, Inc.
SWTXDelisted Jul 1, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001773427
SpringWorks Therapeutics, Inc. was delisted on Jul 1, 2025; its insiders filed their last Form 4 on Jul 2, 2025; 223 institutions reported holding it in 13F filings for Q2 2025, worth $3.65B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q2 2024
Institutional positions in SpringWorks Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 209
- −6 vs. Q1 2024
- Shares held
- 77.2M
- −1.05M (−1.3%) vs. Q1 2024
- Total value
- $2.91B
- −$941.6M (−24.5%) vs. Q1 2024
- New holders
- 31
- 95 more added
- Sold out
- 37
- 55 more reduced
2 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SWTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $47 |
| Q1 2026 | 1 | $47 |
| Q4 2025 | 2 | $2.18M |
| Q3 2025 | 3 | $2.16M |
| Q2 2025 | 223 | $3.65B |
| Q1 2025 | 306 | $3.29B |
| Q4 2024 | 216 | $2.92B |
| Q3 2024 | 226 | $2.59B |
| Q2 2024 | 209 | $2.91B |
| Q1 2024 | 217 | $3.85B |
| Q4 2023 | 180 | $2.75B |
| Q3 2023 | 147 | $1.58B |
| Q2 2023 | 142 | $1.82B |
| Q1 2023 | 149 | $1.70B |
| Q4 2022 | 137 | $1.73B |
| Q3 2022 | 148 | $1.80B |
| Q2 2022 | 144 | $1.36B |
| Q1 2022 | 136 | $2.79B |
| Q4 2021 | 144 | $2.82B |
| Q3 2021 | 142 | $2.86B |
| Q2 2021 | 135 | $3.69B |
| Q1 2021 | 137 | $3.23B |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding SpringWorks Therapeutics, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Marshall Wace, LLP | 2,333,117 | $87.9M | 0.12% | −633,505−21.4% | Reduced |
| Maverick Capital LtdSuperinvestorMaverick Capital | 2,600,524 | $98.0M | 1.86% | +691,894+36.3% | Added |
| State Street Corp | 3,086,845 | $116.3M | 0.01% | +125,221+4.2% | Added |
| Boxer Capital, LLC | 3,421,541 | $128.9M | 6.79% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 3,602,234 | $135.7M | 0.02% | −508,228−12.4% | Reduced |
| Deep Track Capital, LP | 3,700,000 | $139.4M | 4.16% | +220,147+6.3% | Added |
| BlackRock Inc. | 5,619,260 | $211.7M | 0.00% | +180,403+3.3% | Added |
| Vanguard Group Inc | 6,544,413 | $246.5M | 0.00% | +15,088+0.2% | Added |
| FMR LLC | 11,112,391 | $418.6M | 0.03% | +44,365+0.4% | Added |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −1,489,814−100.0% | Sold out |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −1,283,176−100.0% | Sold out |
| Rubric Capital Management LP | 0 | $0 | 0.00% | −426,768−100.0% | Sold out |
| Altitude Crest Partners Inc. | 0 | $0 | 0.00% | −128,842−100.0% | Sold out |
| Polar Asset Management Partners Inc. | 0 | $0 | 0.00% | −128,000−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −68,667−100.0% | Sold out |
| Alps Advisors Inc | 0 | $0 | 0.00% | −52,048−100.0% | Sold out |
| Lighthouse Investment Partners, LLC | 0 | $0 | 0.00% | −40,733−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −33,751−100.0% | Sold out |
| Moody Aldrich Partners LLC | 0 | $0 | 0.00% | −18,080−100.0% | Sold out |
| Campbell & CO Investment Adviser LLC | 0 | $0 | 0.00% | −16,644−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −14,685−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −15,034−100.0% | Sold out |
| Silphium Asset Management Ltd | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −8,260−100.0% | Sold out |
| New York Life Investment Management LLC | 0 | $0 | 0.00% | −7,248−100.0% | Sold out |
| Creative Planning | 0 | $0 | 0.00% | −5,246−100.0% | Sold out |
| Farallon Capital Management, L.L.C. | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Financial Security Advisor, Inc. | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −4,894−100.0% | Sold out |
| Bayshore Asset Management, LLC | 0 | $0 | 0.00% | −4,852−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −4,673−100.0% | Sold out |
| Xponance, Inc. | 0 | $0 | 0.00% | −4,164−100.0% | Sold out |
| Mackenzie Financial Corp | 0 | $0 | 0.00% | −4,137−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −4,075−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −4,000−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −3,670−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −2,123−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −1,493−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −288−100.0% | Sold out |
| nVerses Capital, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Hollencrest Capital Management | 0 | $0 | 0.00% | −98−100.0% | Sold out |
| Westend Capital Management, LLC | 0 | $0 | 0.00% | −28−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −23−100.0% | Sold out |
| Geneos Wealth Management Inc. | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Parallax Volatility Advisers, L.P. | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| Riggs Asset Managment Co. Inc. | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Credit Suisse AG | – | – | – | – | Not filed |
| Cutler Group LP | – | – | – | – | Not filed |